KVP Capital Advisors »

Tandem Diabetes Care shares owned by KVP Capital Advisors

Quarter-by-quarter ownership of Tandem Diabetes Care (TNDM) shares owned by KVP Capital Advisors from 13F filings

Historical chart of KVP Capital Advisors investment in Tandem Diabetes Care

Tip: Access up to 7 years of quarterly data

All positions including Tandem Diabetes Care held by KVP Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tandem Diabetes Care by KVP Capital Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $4.5M 301k 15.09

More positions owned by KVP Capital Advisors

Praxis Precision Medicines I Com New (PRAX)
Aadi Bioscience (WHWK)
Erasca (ERAS)
Trevi Therapeutics (TRVI)
Sutro Biopharma Com Shs (STRO)
Tango Therapeutics (TNGX)
Mbx Biosciences (MBX)
Protagonist Therapeutics (PTGX)
Edgewise Therapeutics (EWTX)
Tandem Diabetes Care Com New (TNDM)
Disc Medicine (IRON)
Savara (SVRA)
Arrivent Biopharma (AVBP)
Insmed Com Par $.01 (INSM)
Achieve Life Sciences (ACHV)

View all positions for KVP Capital Advisors

Top funds holding Tandem Diabetes Care

BlackRock
UBS Group
Sessa Capital IM
Vanguard Portfolio Management
First Light Asset Management
Vanguard Capital Management
State Street Corporation
Jennifer Ranahan
Jennison Associates
Paradice Investment Management
Jacobs Levy Equity Management
Freestone Grove Partners
Citadel Advisors
Geode Capital Management
Driehaus Capital Management

View all funds holding Tandem Diabetes Care